Zobrazeno 1 - 10
of 599
pro vyhledávání: '"Nahum Méndez-Sánchez"'
Autor:
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Publikováno v:
Annals of Hepatology, Vol 28, Iss 6, Pp 101138- (2023)
Non-alcoholic fatty liver disease (NAFLD) represents a global public health burden. Despite the increase in its prevalence, the disease has not received sufficient attention compared to the associated diseases such as diabetes mellitus and obesity. I
Externí odkaz:
https://doaj.org/article/a3116ef3e42444d488c75a7f124b7837
Publikováno v:
Pathogens, Vol 13, Iss 4, p 339 (2024)
Chronic hepatitis C virus infection is an important cause of liver cirrhosis, hepatocellular carcinoma and death. Furthermore, it is estimated that about 40–70% of patients develop non-hepatic alterations in the course of chronic infection. Such ma
Externí odkaz:
https://doaj.org/article/ad9ede48d1e74b9288d10b508b9670a0
Autor:
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3694 (2024)
Metabolic-associated fatty liver disease (MAFLD) includes several metabolic dysfunctions caused by dysregulation in the brain–gut–liver axis and, consequently, increases cardiovascular risks and fatty liver dysfunction. In MAFLD, type 2 diabetes
Externí odkaz:
https://doaj.org/article/fb1b62dc0cf34685913a804f347df3fe
Autor:
Zhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Andrea Mancuso, Cyriac Abby Philips, Frank Tacke, Metin Basaranoglu, Massimo Primignani, Mostafa Ibrahim, Yu Jun Wong, Filipe Gaio Nery, Rolf Teschke, Carlos Noronha Ferreira, Alberto E. Muñoz, Kanokwan Pinyopornpanish, Thierry Thevenot, Shivaram Prasad Singh, Arpan Mohanty, Sanjaya K. Satapathy, Lorenzo Ridola, Hitoshi Maruyama, Evangelos Cholongitas, Giovanni Battista Levi Sandri, Li Yang, Shalimar, Yongping Yang, Erica Villa, Aleksander Krag, Florence Wong, Rajiv Jalan, Alastair O’Brien, Mauro Bernardi, Xingshun Qi
Publikováno v:
JHEP Reports, Vol 5, Iss 8, Pp 100785- (2023)
Background & Aims: Numerous studies have evaluated the role of human albumin (HA) in managing various liver cirrhosis-related complications. However, their conclusions remain partially controversial, probably because HA was evaluated in different set
Externí odkaz:
https://doaj.org/article/b3fc9b951e9e4fe1a4eae57800e9c550
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 28, Iss 12, p 359 (2023)
Stem cell therapy offers a promising avenue for advanced liver disease cases as an alternative to liver transplantation. Clinical studies are underway to explore the potential of stem cells from various sources in treating different liver diseases. H
Externí odkaz:
https://doaj.org/article/8178a1b8beb44c03bb0f81c6a27d5b58
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/23b5f40593304097a6051d610f1ff511
Autor:
Zobair M. Younossi, Yusuf Yilmaz, Mohamed El‐Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez‐Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K. Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
Publikováno v:
Hepatology Communications, Vol 6, Iss 10, Pp 2860-2866 (2022)
Abstract Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID‐19) infection and pandemic‐related life disruption. We assessed the impact of the COVID‐19 pandemic on patients
Externí odkaz:
https://doaj.org/article/84014429ef074574bdf4a6a0d13c9f95
Autor:
Luis Antonio Díaz, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, Blanca Norero, Oscar Corsi, Gonzalo Pizarro, Sergio García, Eduardo Fuentes-López, Edmundo Martinez, Patricia Guerra Salazar, Roberta C. Araújo, Mario Reis Alvares-Da-Silva, Florencia D. Pollarsky, Nelia Hernandez, Juan Carlos Restrepo, Mirtha Infante, Enrique Carrera, Abel Sanchez, Marcos Girala, Martín Padilla, Javier Díaz, Martín Tagle, Melisa Dirchwolf, Manuel Mendizabal, Mariana Lazo, Catterina Ferreccio, Thomas G. Cotter, Mayur Brahmania, Nahum Méndez-Sánchez, Juan Pablo Roblero, Winston Dunn, Patrick S. Kamath, Ashwani K. Singal, Ramón Bataller, Marco Arrese, Juan Pablo Arab
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 101031- (2023)
Introduction and Objectives: Although most cases of HCC occur in patients with advanced liver disease and there are effective screening methods, health policies aimed at preventing and detecting HCC are not often on the agenda of government initiativ
Externí odkaz:
https://doaj.org/article/166303eaa2224c81b851e584c37e1ac4
Autor:
Shreya C. Pal, Stephany M. Castillo-Castañeda, Luis E. Díaz-Orozco, Mariana M. Ramírez-Mejía, Rita Dorantes-Heredia, Rogelio Alonso-Morales, Mohammed Eslam, Frank Lammert, Nahum Méndez-Sánchez
Publikováno v:
Genes, Vol 14, Iss 10, p 1935 (2023)
Gallstone disease and metabolic dysfunction-associated fatty liver disease (MAFLD) share numerous common risk factors and progression determinants in that they both manifest as organ-specific consequences of metabolic dysfunction. Nevertheless, the p
Externí odkaz:
https://doaj.org/article/ee3ca3624e3d474282229334c0afdf75
Autor:
Shreya C. Pal, Nahum Méndez-Sánchez
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 14 (2023)
Metabolic-associated fatty liver disease (MAFLD) is a highly prevalent disease with increasing prevalence worldwide. Currently, no universal screening methods have been standardized, even when this disease poses a major health burden. MAFLD as a spec
Externí odkaz:
https://doaj.org/article/500192d48ae84c93b00e5217cf721a25